Abstract: A method for re-refining used oils comprises contacting feedstock comprising purified used oil with extraction solvent to perform continuous liquid-liquid solvent extraction, to produce an extract stream comprising the extraction solvent and an extract dissolved in the extraction solvent. The feedstock and the extraction solvent are agitated by a variable speed agitator during the solvent extraction at a selected agitation speed. The extract is separated from the extraction solvent and subjected to a continuous flow liquid phase hydrogenation treatment to produce an oil product. A system for performing the method includes a purification unit for purifying the used oil; an extraction column for extracting the extract from the feedstock; and a continuous flow liquid phase hydrogenation unit. The extraction column comprises an agitator configured to agitate the feedstock and the extraction solvent flowing through the extraction column at a variable agitation speed.

Abstract: Disclosed herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, that are inhibitors of Polo Like Kinase 4 (PLK4). Also disclosed herein are pharmaceutical compositions comprising the compounds of Formula (I), or pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable excipients. Further disclosed herein are methods of treating cancer in a subject in need thereof, comprising administering to the subject an amount of a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.

Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.

Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.

Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: A modular pegboard electrical board comprising an expandable grid of electrical leads to allow connection of various electronic implements, including light fixtures, fluorescent lamp ballasts and heating lamps. A rectangular pegboard having internal circuitry provides columns of electrical leads, whereby every four consecutive columns form a hot-ground-neutral-ground combination of vertical leads in parallel. The combination allows for connection of a two or three-wire interface to attach anywhere on the board surface, including electrical socket adapters and specific light fixture wiring. The pegboard-style board allows a latch mechanism from a light fixture or electrical device to affect an electrical connection at a specific lead.

Abstract: A mini-plot is generated using the actual raw measurement data, and gives a preview of a full-sized plot which is displayed when a user expresses interest in the mini-plot. In some embodiments, the mini-plot is sufficiently resolved to provide the user with graphical information about the measurement data. In some embodiments, the mini-plot is updated upon receiving new measurement data from an ongoing experiment. In some embodiments, the mini-plot is a mini-chromatogram. In some embodiments, the mini-plot is displayed in a table along with textual and/or numerical measurement data for an experiment (e.g., in listing textual and/or numerical chromatography data).

Abstract: A modular pegboard electrical board comprising an expandable grid of electrical leads to allow connection of various electronic implements, including light fixtures, fluorescent lamp ballasts and heating lamps. A rectangular pegboard having internal circuitry provides columns of electrical leads, whereby every four consecutive columns form a hot-ground-neutral-ground combination of vertical leads in parallel. The combination allows for connection of a two or three-wire interface to attach anywhere on the board surface, including electrical socket adapters and specific light fixture wiring. The pegboard-style board allows a latch mechanism from a light fixture or electrical device to affect an electrical connection at a specific lead.

Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest using methylcellulose comprising fluorescent protein A or G to improve detection and cloning. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: DNA sequences that increase peptide chain expression when operably linked to a gene encoding the peptide chain and methods of generating a peptide chain expression host cell using the foregoing are disclosed. Peptide chain expression host cells are also disclosed.

Abstract: DNA sequences that increase peptide chain expression when operably linked to a gene encoding the peptide chain and methods of generating a peptide chain expression host cell using the foregoing are disclosed. Peptide chain expression host cells are also disclosed.

Abstract: Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.

Abstract: The present invention in the field of biotechnology, provides methods and compositions for providing enhanced growth of, and/or protein production from, cultured mammalian host cells used for the production of commercially useful amounts of expressed proteins, by the use of at least one Bcl2 encoding nucleic acid provided or transcribed in the host cell.

Abstract: The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.

Abstract: The invention provides a genetic screening method for identifying a transfected cell expressing the polypeptide of interest. The methods allows for high throughput screening of recombinant cells for elevated levels of expression of the polypeptide of interest. The invention also provides capture media, formulations and methods of making and using thereof.

Abstract: The present invention relates to methods and compositions for chemically defined media for growth of mammalian cells for production of commercially useful amounts of expressed proteins.

Abstract: A porous media gas burner is adapted to operate in a pressurized environment. The burner may have three zones: a mixing zone, an ignition zone and a reaction zone. The burner may be used as a downhole burner in a formation heat treatment method for oil and gas wells.

Abstract: The present invention relates to clonal myeloma cell lines that have the ability to grow continuously in chemically defined media. The present invention also relates to the production of proteins in clonal myeloma cell lines and any cell lines derived therefrom. The present invention further relates to methods for identifying cell lines capable of growing in chemically defined media.

Abstract: The present invention in the field of biotechnology, provides methods and compositions for providing enhanced growth of, and/or protein production from, cultured mammalian host cells used for the production of commercially useful amounts of expressed proteins, by the use of at least one Bcl2 encoding nucleic acid provided or transcribed in the host cell.